JP-8 jet fuel exposure potentiates tumor development in two experimental model systems

Area of Science:

• Environmental Health
• Immunology
• Oncology

Background:

• JP-8 jet fuel is widely used by the US Air Force, but its health effects are not fully understood.
• Previous research indicates JP-8 exposure can suppress immune responses, evidenced by increased interleukin-10 and prostaglandin E2.
• This study investigates the potential link between JP-8 exposure and tumor promotion.

Purpose of the Study:

• To determine if JP-8 jet fuel exposure promotes tumor growth and metastasis.
• To evaluate the impact of JP-8 exposure timing on tumor development.

Main Methods:

• Utilized the syngeneic B16 tumor model in mice.
• Mice were exposed to JP-8 (1000 mg/m3, 1 h/day) either 7 days before tumor cell injection or at the time of injection.
• Tumor growth, lung colonies, and metastatic spread were assessed 17 days post-injection.

Main Results:

• JP-8 exposure significantly potentiated B16 tumor growth and metastasis.
• Pre-exposure to JP-8 resulted in an 8.7-fold increase in tumor numbers; exposure at tumor induction showed a 5.6-fold increase.
• In a subcutaneous model, JP-8 exposure accelerated mortality in tumor-bearing mice, despite not affecting primary tumor growth.

Conclusions:

• Low-concentration JP-8 jet fuel exposure exerts significant immunosuppressive effects.
• These immune suppressive effects can lead to increased tumor formation and metastasis.
• Accelerated mortality in tumor-bearing mice suggests JP-8 exposure poses a serious health risk.